Neumora Therapeutics, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Neumora Therapeutics, Inc.
Portfolio Pulse from
A securities class action lawsuit has been filed against Neumora Therapeutics, Inc. in the Southern District of New York. The lawsuit pertains to the company's IPO on September 15, 2023, where 14.7 million shares were sold at $17.00 each. The lead plaintiff deadline is April 7, 2025.
March 03, 2025 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Neumora Therapeutics is facing a class action lawsuit related to its IPO, which could impact investor confidence and stock price.
The lawsuit directly targets Neumora's IPO, which is a significant event for the company. Legal challenges can lead to uncertainty and negatively affect investor sentiment, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100